A | B | C | D | E | F | G | H | I | J | K | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Moral weights and discount rate | unit | type | GiveWell | GW discussion | Notes | ||||||
2 | Moral weights | |||||||||||
3 | ||||||||||||
4 | Consumption Increases | GW's 2020 write-up on moral weights | Our model accounts for changes in the natural log of consumption. The logarithmic model captures the idea that money has diminishing value as you get more and more of it. For example, our model considers a 50% increase in income as a little better than 50% as good as an 100% increase in income. | |||||||||
5 | Value assigned to doubling consumption for one person for one year | UoV | input | 1 | ||||||||
6 | ||||||||||||
7 | Averting deaths | |||||||||||
8 | Value assigned to averting the death of an individual under 5 from malaria | UoV | input | 116 | GW's analysis of moral weights for malaria | |||||||
9 | Value assigned to averting the death of an individual 5 or older from malaria | UoV | input | 73 | GW's analysis of moral weights for malaria | |||||||
10 | Value assigned to averting the death of a 6- to 59-month-old child (VAS) | UoV | input | 119 | GW's analysis of moral weights for vitamin A supplementation | |||||||
11 | Value assigned to averting the death of an individual under 5 from vaccine-preventable diseases | UoV | input | 116 | We use the same value we calculated for malaria because we have not attempted to calculate the age distribution of mortalities among children under 5 for all vaccine-preventable diseases. We would guess that this age distribution of mortalities is similar to the age distribution of mortalities for deaths caused by malaria among children under 5. | |||||||
12 | Value assigned to averting the death of an individual 5-14 years old from vaccine-preventable diseases | UoV | input | 134 | GW's analysis of moral weights for New Incentives | |||||||
13 | Value assigned to averting the death of an individual 15-49 years old from vaccine-preventable diseases | UoV | input | 104 | GW's analysis of moral weights for New Incentives | |||||||
14 | Value assigned to averting the death of an individual 50-74 years old from vaccine-preventable diseases | UoV | input | 42 | GW's analysis of moral weights for New Incentives | |||||||
15 | ||||||||||||
16 | Derived value assignments | |||||||||||
17 | ||||||||||||
18 | Value assigned to increasing consumption by 10% for one person for one year | UoV | calc | 0.14 | ||||||||
19 | Value assigned to increasing consumption by 25% for one person for one year | UoV | calc | 0.32 | ||||||||
20 | Value assigned to increasing ln(consumption) by one unit for one person for one year | UoV | calc | 1.44 | ||||||||
21 | Value assigned to increasing consumption by 10% for 100 people for one year | UoV | calc | 13.8 | ||||||||
22 | Value assigned to increasing consumption by 25% for 100 people for one year | UoV | calc | 32.2 | ||||||||
23 | ||||||||||||
24 | Implications | |||||||||||
25 | ||||||||||||
26 | Value of an over-5 life saved relative to an under-5 life saved | UoV | calc | 63% | ||||||||
27 | Value of doubling consumption for one person for one year relative to saving the life of a child under-5 (AMF) | UoV | calc | 1% | ||||||||
28 | ||||||||||||
29 | Discount rate | |||||||||||
30 | ||||||||||||
31 | Discount rate components | GW's write-up on discount rates | ||||||||||
32 | Improving circumstances over time | % | input | 1.7% | ||||||||
33 | Compounding non-monetary benefits | % | input | 0.9% | ||||||||
34 | Temporal uncertainty | % | input | 1.4% | ||||||||
35 | Pure time preference (donors) | % | input | 0.0% | ||||||||
36 | Pure time preference (program participants) | % | input | 0.0% | ||||||||
37 | Overall discount rate | % | calc | 4.0% | ||||||||
38 |